Free Trial
→ Everyone’s watching Nvidia right now. Here’s why I’m excited. (From Timothy Sykes) (Ad) Buy VKTX Stock  Free VKTX Stock Alerts

Viking Therapeutics (VKTX) SEC Filings & 10K Form

Viking Therapeutics logo
$26.98 -0.75 (-2.70%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$27.04 +0.06 (+0.24%)
As of 05/23/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Viking Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/12/2025
9:43 AM		FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SCHEDULE 13G/A
04/24/2025
3:37 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
4:25 PM		Viking Therapeutics (Filer)
Form DEFR14A
04/23/2025
4:26 PM		Viking Therapeutics (Filer)
Form DEFA14A
04/23/2025
3:01 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
9:00 AM		BlackRock, Inc. (Filed by)
Viking Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
6:26 PM		FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
6:05 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4/A
04/08/2025
4:23 PM		Viking Therapeutics (Filer)
Form DEFA14A
04/08/2025
4:25 PM		Viking Therapeutics (Filer)
Form ARS
04/02/2025
5:29 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:05 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:32 PM		Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/06/2025
7:15 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:16 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:11 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:12 PM		FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM		Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:32 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:25 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:16 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:22 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
5:13 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
12:54 PM		VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
11/04/2024
5:31 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
8:48 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:37 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
6:27 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
6:28 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:10 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:00 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
3:09 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
11:26 AM		STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
09/20/2024
8:20 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:21 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:29 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
6:23 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
6:23 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This Is The Moment You Betray Trump (Or Prove Them Wrong) (Ad)

They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.

Protect your savings without betraying Trump
08/19/2024
7:11 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:13 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:00 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
6:47 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
7:03 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:38 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:05 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:05 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:05 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:55 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
4:56 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
4:58 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2024
4:00 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:10 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
6:10 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VKTX) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored